Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Ministry of Health and Family Welfare (MoH&FW) has reconstituted the Central Expert Committee tasked with determining compensation for patients implanted with faulty Articular Surface Replacement (ASR) hip implants. These implants had caused widespread health issues in India, necessitating regulatory action to ensure fair redressal for affected patients.
Source: bit.ly/4gjSZok

2. The Delhi government has urged the Ministry of Health and Family Welfare (MoH&FW) to amend the Clinical Establishments (Registration and Regulation) Act, 2010 (2010 Act) to make it applicable in Delhi. Under the current framework, the Act cannot be operational due to the Delhi Nursing Home Registration Act, 1953, being listed in the saving clause. An amendment is required for Delhi to regulate pathology laboratories under the 2010 Act effectively.
Source: bit.ly/3OKo60y

3. The Delhi High Court has directed the central government to consider a plea by the Center for Ichthyosis Related Members Foundation to recognize Ichthyosis as a disability under the Rights of Persons with Disabilities (RPwD) Act, 2016. This rare genetic skin disorder, characterized by rough, scaly skin lacks a permanent cure and significantly impacts the mental and physical well-being of patients. This classification would help mitigate discrimination and enhance support mechanisms.
Source: bit.ly/3OIfIi0

4. The Ministry of Health and Family Welfare (MoH&FW) has urged states for making snakebite cases and deaths a notifiable disease under state public health laws. Mandatory reporting by government and private health facilities aims to enhance surveillance and address factors contributing to snakebite mortality. The initiative is part of the broader action plan targeting a reduction in snakebite-related deaths by 2030 under National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE).
Source: bit.ly/3OMt38U

5. The Bharatiya Vayuyan Vidheyak, 2024, a bill replacing the Aircraft Act of 1934, was passed in Parliament during the Winter Session. The legislation aims to streamline aviation manufacturing, maintenance, and regulatory processes, ensuring ease of doing business.
Source: bit.ly/3VpbeAJ

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Supreme Court has stayed the repeal of Sec. 170 of the Drugs, Rules 1945 which regulated Advertisement of AYUSH products by the AYUSH Ministry, to address the ultra-vires nature its policy regarding AYUSH advertisement.
Source: bit.ly/4e4qOZz
Source: bit.ly/4dDnIvK

2. The National Commission for the Indian System of Medicine has restated its position, as it has taken in an advisory issued earlier on 16th July, that practitioners of AYUSH medicine should not represent themselves as “Cannabis experts” as it may constitute a “Misrepresentation of qualification” under Regulation 27 of the National Commission for Indian System of Medicine (Ethics and Registration) Regulation, 2023.
Source: bit.ly/3APXRls
Source: bit.ly/4cLHaFl

3. The Supreme Court has issued a Notice to the Central and State Governments and their departments, seeking a response on policy position regarding braille accessibility and integration into (1) Medical packaging, (2) Consumer Goods packaging, and (3) Implementation of braille in all aspects of public and private sectors.
Source: bit.ly/3AHLUOP

4. The office of Director General of Foreign Trade has issued draft modalities for setting up E-commerce Export Hubs which will support infrastructure for cross-border e-commerce trade, and has requested for submission of detailed proposals for set-up of E-commerce Export Hubs.
Source: bit.ly/3ASWEd6

5. The Drug Enforcement Administration, part of the United States Department of Justice has issued a notice that it will be holding hearings regarding the subject-matter of a Federal level reclassification of Cannabis from a Schedule I to Schedule III substance.
Source: bit.ly/4dCiQXN